NOT KNOWN FACTUAL STATEMENTS ABOUT ABBV-744 PRECLINICAL STUDIES AND RESULTS

These side effects had been notably milder in comparison with an inhibitor of both bromodomains. A detailed molecular Investigation also revealed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen TaylorFeasible new approaches for the prognosis and treatment of AML. (A) The identification o